---
title: Monitor involuntary movements and tremor
nct_id: NCT06490861
phase: NA
status: RECRUITING
sponsor: Paragit ApS
study_type: INTERVENTIONAL
canonical_url: "https://parkinsonspathways.com/trial/NCT06490861"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT06490861"
last_fetched: "2026-05-10T14:05:39.616Z"
source: "Parkinson's Pathways (curated)"
---
# Monitor involuntary movements and tremor

**Goal (in five words):** Monitor involuntary movements and tremor

**Official Title:** An Open Multi-centre Investigation to Evaluate the Performance of the Paragit Sleeve With build-in sEMG Sensors, Kinetic Sensors, and Smart-textile to Measure and Monitor Motor Symptoms and Treatment-induced Dyskinesia in Patients With Parkinson's Disease

**Trial ID:** [NCT06490861](https://clinicaltrials.gov/study/NCT06490861)

## Key Facts

- **Phase:** NA
- **Status:** RECRUITING
- **Study Type:** INTERVENTIONAL
- **Sponsor:** Paragit ApS
- **Target Enrollment:** 25 participants
- **Start Date:** 2023-12-19
- **Completion Date:** 2024-08-01
- **Conditions:** Parkinson Disease
- **Interventions:** Paragit
- **Intervention Types:** DEVICE

## Summary For Families

The goal is to see whether a wearable smart sleeve can accurately measure and monitor Parkinson's motor symptoms and levodopa-induced dyskinesia, giving clinicians objective data to guide treatment. The Paragit sleeve is a smart-textile you wear on an arm or leg with built-in surface EMG sensors and kinetic motion sensors that record muscle electrical activity and movement patterns to detect rigidity, tremor, bradykinesia, and involuntary dyskinesia, it is a noninvasive monitor that does not change medications but collects data alongside your usual levodopa. The trial seeks adults 50 and older with a clinical Parkinson's diagnosis who experience at least two of those symptoms daily and can give informed consent; people with skin allergies to stainless steel, silicone, or polyester, an MMSE under 24, or other neurological diseases are excluded.

## Eligibility

- **Minimum age:** 50 Years
- **Sex:** ALL

### Full Criteria

```
Inclusion Criteria:

1. Parkinson disease: Clinically diagnosed
2. Age ≥ 50 (not in the childbearing aged as defined by Statistics Denmark, 15-49)
3. Experiencing at least two of following symptoms and/or side effect on a daily basis:

   * Rigidity
   * Tremor
   * Bradykinesia
   * Dyskinesia (treatment side effect)
4. Provision of informed consent, i.e., the subject must be able to:

   * Read and understand the Patient Information and Consent Form
   * Sign the Patient Information and Consent Form.

Exclusion Criteria:

1. Known allergy/hypersensitivity to any material in direct contact with the skin (stainless steel, silicone and polyester)
2. MMSE \<24
3. Other neurological diseases
```

## Locations (1)

- Hospital Beata María Ana, Madrid, Spain _(40.4165, -3.7026)_
  - Juan Pablo Romero, PhD — (CONTACT) — +34 — p.romero.prof@ufv.es

---

*Canonical: https://parkinsonspathways.com/trial/NCT06490861*  
*HTML version: https://parkinsonspathways.com/trial/NCT06490861*  
*Source data: https://clinicaltrials.gov/study/NCT06490861*